Cipla Limited
CIPLA
Rang in aandelen
#1816
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Aandeelprijs
$14.61
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$11.81B
Verandering (1 dag)
-0.11%
Verandering (1 jaar)
-21.65%
Land
IN
Handel Cipla Limited (CIPLA)
Categorie
Healthcare
Aandelsplitsingen voor Cipla Limited (CIPLA)
Het aandeel Cipla Limited (symbool: CIPLA) heeft in totaal 4 splitsingen ondergaan.
De meest recente splitsing vond plaats op Apr 24, 2006.
Eén aandeel CIPLA dat vóór Oct 18, 1999 werd gekocht, staat nu gelijk aan 112.5 aandelen CIPLA.
De meest recente splitsing vond plaats op Apr 24, 2006.
Eén aandeel CIPLA dat vóór Oct 18, 1999 werd gekocht, staat nu gelijk aan 112.5 aandelen CIPLA.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2006-04-24 | 5:2 | x2.5 | x112.5 |
| 2004-05-11 | 5:1 | x5 | x45 |
| 1999-10-21 | 3:1 | x3 | x9 |
| 1999-10-18 | 3:1 | x3 | x3 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
